Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

No products in the cart.

SIDNOFARM™ tablets 2mg, 30pcs

🔥 9 items sold in last 3 hours
6 people are viewing this product
Brand:
Active Ingredient:

Manufacturer:

$24.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

ABAKTAL™ tablets 400mg, 10pcs

$42.00
Add to cart

ABISIL™ oily solution 20% (15ml), 1pc

$54.00
Add to cart

Analogs of SIDNOFARM™

MOLSIDOMINE-SZ™ tablets 2mg, 30pcs

$19.00
Add to cart

MOLSIDOMINE-SZ™ tablets 4mg, 30pcs

$14.00
Add to cart

Table of Contents

SIDNOFARM™ 2mg Tablets Buy Online

SIDNOFARM Tablets: A Comprehensive Overview

Experiencing chest pain or discomfort? SIDNOFARM tablets may offer relief. This comprehensive overview explores its uses, mechanisms, and important considerations.

SIDNOFARM, containing the active ingredient molsidomine, is a peripheral vasodilator and antianginal agent. It’s designed to alleviate symptoms associated with angina pectoris, a condition marked by chest pain due to reduced blood flow to the heart.

Its effectiveness stems from its ability to relax blood vessels, particularly veins. This improves blood flow, reduces the workload on the heart, and consequently eases chest pain. The medication is available in 2mg tablets, typically dispensed in packs of 30.

Understanding SIDNOFARM

SIDNOFARM tablets are a medication primarily used in the management of angina pectoris, a heart condition characterized by chest pain due to inadequate blood supply to the heart muscle. The active ingredient, molsidomine, works by relaxing blood vessels, improving circulation and reducing the strain on the heart. This leads to a decrease in the frequency and severity of angina attacks.

Unlike some other heart medications, SIDNOFARM’s mechanism of action involves a unique process. Molsidomine itself isn’t directly responsible for vasodilation; instead, it’s metabolized in the body into SIN-1, a potent vasodilator. SIN-1 selectively targets veins, causing them to widen and reducing venous return to the heart. This, in turn, lessens the heart’s workload and improves oxygen delivery to the cardiac muscle.

The medication is typically prescribed for the prevention of angina attacks, particularly those triggered by physical exertion. It is not intended for the immediate treatment of an acute angina episode. Patients should always consult their physician for proper diagnosis and treatment plan. Remember, self-medicating can be dangerous; always follow your doctor’s instructions.

While SIDNOFARM primarily addresses angina, its effects extend to other aspects of cardiovascular health. By reducing venous pressure, it can also indirectly impact pulmonary artery pressure and left ventricular filling pressure. These effects contribute to the overall improvement in cardiac function and patient well-being. This multifaceted approach makes it a valuable tool in managing cardiovascular disease.

Mechanism of Action

SIDNOFARM’s therapeutic effect hinges on its unique mechanism of action, which differs significantly from many other vasodilators. The key lies in its active ingredient, molsidomine. Unlike direct vasodilators, molsidomine doesn’t directly relax blood vessels. Instead, it undergoes a metabolic transformation within the body.

This metabolic process converts molsidomine into its active metabolite, SIN-1 (3-morpholino-sydnonimine). SIN-1 is a potent nitric oxide (NO) donor. This means it triggers the release of nitric oxide, a crucial molecule responsible for vascular smooth muscle relaxation.

The release of nitric oxide by SIN-1 leads to a selective dilation of peripheral veins. This preferential venodilation reduces venous return to the heart, decreasing preload (the volume of blood in the heart before contraction). The reduced preload lessens the workload on the heart, improving its efficiency and reducing oxygen demand.

Furthermore, SIDNOFARM exhibits antiplatelet effects by inhibiting platelet aggregation. This effect contributes to its overall cardiovascular benefits by reducing the risk of blood clot formation. The combined effects of venodilation and antiplatelet activity contribute to the drug’s efficacy in managing angina and improving overall cardiovascular health.

This indirect mechanism of action, involving the conversion of molsidomine to SIN-1 and subsequent NO release, offers a distinctive approach to managing cardiovascular issues, compared to drugs that directly relax blood vessels. The selective venodilation is a key factor in its effectiveness and tolerability.

Therapeutic Uses

SIDNOFARM tablets find their primary application in the prophylaxis of angina pectoris. This means it’s used to prevent attacks of chest pain, rather than treating an attack that’s already underway. Its effectiveness stems from its ability to reduce the workload on the heart and improve blood flow.

The drug’s mechanism, focusing on venodilation (widening of veins), reduces the amount of blood returning to the heart, thereby decreasing the pressure and strain on the heart muscle. This is particularly beneficial for individuals with stable angina, where chest pain is typically triggered by physical activity or stress.

While primarily employed for angina prevention, SIDNOFARM’s effects on blood vessel dilation and platelet aggregation might offer additional therapeutic advantages. These effects could contribute to improved overall cardiovascular health. However, further research may be necessary to fully understand these secondary benefits.

It’s crucial to remember that SIDNOFARM is not a treatment for acute angina attacks. Patients experiencing sudden, severe chest pain should seek immediate medical attention. This medication should only be used as prescribed by a physician, following careful evaluation of the patient’s overall health condition.

The use of SIDNOFARM should be part of a comprehensive approach to managing cardiovascular health. Lifestyle modifications, such as diet and exercise, are crucial complements to medication in achieving optimal outcomes. Always consult a healthcare professional for personalized guidance.

Dosage and Administration

SIDNOFARM tablets are typically administered orally, and the dosage should always be determined and monitored by a healthcare professional. The recommended dose will vary depending on individual patient needs and response to treatment. Improper dosage can lead to adverse effects, so adhering to prescribed guidelines is critical.

Generally, SIDNOFARM tablets are swallowed whole with an adequate amount of liquid. They can be taken with or without food, but consistency in timing is recommended for optimal efficacy. The physician will establish a suitable dosing schedule, considering factors such as the severity of the condition and any potential drug interactions.

The usual starting dose is often low and may be gradually increased as needed under medical supervision. This titration approach allows for individual adjustment, ensuring the most effective treatment while minimizing potential side effects. Regular monitoring of blood pressure and other relevant parameters is crucial.

It is extremely important to follow the prescribed dosage regimen precisely. Never alter the dosage or frequency of administration without explicit consultation with your doctor. Adjustments should only be made under professional medical guidance to avoid potential complications or inefficacy.

Patients should inform their healthcare provider of any pre-existing conditions, current medications, or allergies to ensure safe and effective use. Open communication with your physician is essential for optimal management of your condition using SIDNOFARM.

Pros of SIDNOFARM

Advantages

SIDNOFARM offers several key advantages in managing angina pectoris and improving overall cardiovascular health. Its unique mechanism of action, targeting venous dilation, provides a distinct approach compared to other heart medications. This selective action minimizes some of the side effects associated with more generalized vasodilation.

The drug’s effectiveness in preventing angina attacks is a significant advantage for patients. By reducing the heart’s workload and improving blood flow, SIDNOFARM allows individuals to engage in activities they might otherwise avoid due to chest pain. This improved quality of life is a major benefit.

In addition to its antianginal properties, SIDNOFARM exhibits antiplatelet effects. This helps to reduce the risk of blood clot formation, which is a significant factor in cardiovascular diseases. This multifaceted approach contributes to improved overall cardiovascular health.

Many patients find SIDNOFARM to be well-tolerated, with relatively few side effects compared to some other antianginal medications. However, individual responses can vary, and potential side effects should be discussed with a healthcare professional. Always report any unusual symptoms.

The relatively simple administration, involving oral ingestion, enhances patient compliance. This ease of use contributes to better adherence to the prescribed regimen, which is crucial for the successful management of chronic conditions. Remember to always follow your doctor’s instructions.

Advantages

The primary advantage of SIDNOFARM lies in its efficacy in preventing angina attacks. By selectively dilating veins, it reduces the strain on the heart, thereby lessening the likelihood of chest pain episodes. This allows patients greater freedom and improved quality of life.

Another key benefit is its relatively benign side effect profile compared to some other vasodilators. While individual reactions vary, many patients experience minimal discomfort. This improved tolerability contributes to better treatment adherence.

SIDNOFARM’s antiplatelet properties offer an additional layer of cardiovascular protection. By inhibiting platelet aggregation, it contributes to reducing the risk of blood clot formation, a major contributor to heart disease. This added benefit enhances its overall value.

The ease of oral administration simplifies treatment for patients. The simple act of taking a tablet daily contributes to better compliance compared to more complex treatment regimens. This straightforward approach improves patient adherence to the prescribed treatment plan.

Finally, the selective nature of its vasodilatory action, predominantly targeting veins, helps to minimize some of the potential side effects associated with more generalized vasodilation. This targeted approach enhances both safety and tolerability.

Cons of SIDNOFARM

Potential Drawbacks

While SIDNOFARM offers significant benefits, potential drawbacks should be considered. Although generally well-tolerated, some patients may experience adverse effects. These can vary in severity and frequency, highlighting the importance of individual monitoring and reporting to a healthcare provider.

One potential side effect is hypotension (low blood pressure). This is particularly relevant for patients already predisposed to low blood pressure or those taking other medications that lower blood pressure. Careful monitoring is crucial to mitigate this risk.

Headache is another commonly reported side effect. While usually mild and transient, persistent or severe headaches should be reported to a doctor. Adjusting the dosage or exploring alternative treatments might be necessary in such cases.

Gastrointestinal disturbances, such as nausea or diarrhea, are also possible. These effects are typically mild and resolve spontaneously, but persistent symptoms warrant medical attention. Adjusting the timing of medication intake relative to meals may help alleviate such issues.

As with any medication, potential interactions with other drugs exist. It’s crucial to inform your doctor about all medications, supplements, and herbal remedies you are taking to prevent unforeseen complications. This proactive approach is essential for safe and effective treatment.

Potential Drawbacks

While generally well-tolerated, SIDNOFARM can cause hypotension (low blood pressure) in some individuals. This effect is more pronounced in patients already experiencing low blood pressure or those concurrently using other hypotensive medications. Careful monitoring of blood pressure is essential, particularly during initial treatment.

Headaches are a relatively common side effect, often described as mild and transient. However, persistent or severe headaches should prompt consultation with a healthcare professional. Dosage adjustment or alternative treatments may be considered to manage this symptom effectively.

Gastrointestinal upset, including nausea and diarrhea, can occur in some patients. These symptoms are typically mild and self-limiting, but persistent or severe gastrointestinal issues require medical attention. Adjusting the timing of medication intake might alleviate these problems.

The potential for drug interactions necessitates a comprehensive review of all medications, supplements, and herbal remedies currently being used. This thorough assessment is crucial to prevent unintended consequences or reduced efficacy. Always inform your physician of all substances you are taking.

Although rare, more serious side effects are possible. Patients should be vigilant and report any unusual or concerning symptoms immediately to their healthcare provider. Prompt reporting allows for timely intervention and management of potential complications.

Important Considerations

Before starting SIDNOFARM, a comprehensive discussion with your doctor is vital. This consultation should include a thorough review of your medical history, current medications, and any pre-existing conditions. This ensures the safe and appropriate use of the medication.

Patients with severe hypotension (low blood pressure) or those taking other blood pressure-lowering medications should exercise particular caution. Close monitoring of blood pressure is essential to prevent excessive drops in blood pressure. Dosage adjustments might be necessary.

Individuals with liver or kidney impairment should inform their physician before starting treatment. The metabolism and excretion of SIDNOFARM can be affected by these conditions, potentially leading to altered drug levels and increased risk of side effects. Dosage adjustments might be required.

During treatment with SIDNOFARM, regular monitoring of blood pressure and other relevant parameters is recommended. This allows for timely detection of any adverse effects and enables prompt adjustments to the treatment plan as needed. Regular check-ups are crucial.

It’s crucial to remember that SIDNOFARM is for the prevention of angina attacks, not the treatment of acute episodes. Patients experiencing sudden, severe chest pain should seek immediate medical attention. This is a vital distinction to understand.

Pharmacokinetic Properties

Understanding the pharmacokinetic properties of SIDNOFARM is crucial for optimizing its therapeutic use. These properties describe how the drug is absorbed, distributed, metabolized, and eliminated from the body. This knowledge informs dosage regimens and helps predict potential drug interactions.

After oral administration, molsidomine, the active ingredient in SIDNOFARM, is rapidly and almost completely absorbed from the gastrointestinal tract. Bioavailability, or the extent to which the drug reaches the bloodstream, is significant, contributing to its therapeutic efficacy. This efficient absorption ensures that a substantial portion of the ingested drug reaches its target sites.

However, molsidomine itself is not the active therapeutic agent. It undergoes rapid metabolism, primarily in the liver, to form its active metabolite, SIN-1. This conversion is essential for the drug’s vasodilatory effects. The rate of this conversion influences the onset and duration of action.

SIN-1, the active metabolite, has a relatively short half-life, meaning it’s eliminated from the body fairly quickly. This rapid elimination contributes to the drug’s relatively short duration of action, requiring multiple daily doses for sustained therapeutic effects. The short half-life necessitates regular dosing to maintain therapeutic blood levels.

Excretion of both molsidomine and SIN-1 occurs primarily through the kidneys. Patients with impaired renal function may experience altered pharmacokinetic parameters, potentially necessitating dosage adjustments to prevent accumulation and toxicity. Renal function should always be considered when prescribing SIDNOFARM.

  • Sidnofarm™ Tablets 2Mg, 30Pcs Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Sidnofarm™ Tablets 2Mg, 30Pcs Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Sidnofarm™ Tablets 2Mg, 30Pcs Buy Online 6
    [Medical reviewer]

    Dr. Jessica Kerns is a highly accomplished pediatrician and adolescent medicine specialist who serves as a clinical instructor in the Department of Pediatrics at the Icahn School of Medicine at Mount...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “SIDNOFARM™ tablets 2mg, 30pcs”

Your email address will not be published. Required fields are marked

Similar products

NITROSORBIDE tablets 10mg, 60pcs

$6.00
Add to cart

NITROGLYCERIN sublingual capsules 0.5mg, 40pcs

$5.00
Add to cart

NITROGLYCERIN sublingual tablets 0.5mg, 40pcs

$7.00
Add to cart

MONOSAN™ tablets 20mg, 30pcs

$7.00
Add to cart

MONOCINQUE™ tablets 40mg, 30pcs

$13.00
Add to cart

MILDRONATE™ capsules 500mg, 60pcs

$99.00
Add to cart

MEXICOR™ solution for IV and IM injection 50mg/ml (2ml), 10pcs

$26.00
Add to cart

MEXICOR™ solution for IV and IM injection 50mg/ml (5ml), 20pcs

$50.00
Add to cart

CORVALOL™ PLUS FORTE oral drops 25ml, 1pc

$15.00
Add to cart

CARDIOVALEN™ oral drops 25ml, vial 1pc

$13.00
Add to cart

CARDIOACTIVE™ TAURINE tablets 500mg, 120pcs

$59.00
Add to cart

DEPRENORM™ OD prolonged-release tablets 70mg, 30pcs

$26.00
Add to cart

VALIDOL™ sublingual capsules 50mg, 40pcs

$7.00
Add to cart

VALIDOL™ WITH GLUCOSE tablets 60mg, 10pcs

$7.00
Add to cart

VALIDOL™ sublingual tablets 60mg, 20pcs

$7.00
Add to cart

BRAVADIN™ tablets 5mg, 28pcs

$36.00
Add to cart

BRAVADIN™ tablets 5mg, 56pcs

$55.00
Add to cart

BRAVADIN™ tablets 7.5mg, 28pcs

$36.00
Add to cart

HAWTHORN oral solution 25ml, 1pc

$6.00
Add to cart

ACETYLSALICYLIC ACID CARDIO enteric tablets 100mg, 30pcs

$7.00
Add to cart

ASPARKAM™ tablets, 56pcs

$10.00
Add to cart

ASPARKAM-L™ solution for IV injection 45.2mg/ml+40mg/ml (10ml), 10pcs

$14.00
Add to cart

ASPIRIN™ CARDIO enteric-coated tablets 100mg, 98pcs

$22.00
Add to cart

ANTISTEN™ MV prolonged-release tablets 35mg, 60pcs

$29.00
Add to cart
Select your currency